PHAT
PHAT
NASDAQ · Pharmaceuticals

Phathom Pharmaceuticals Inc

$10.06
-0.51 (-4.83%)
As of Mar 24, 10:03 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 14 82%
Hold 3 18%
Sell 0 0%
Price Target
Analyst Price Target +404.4% upside
Low Target $34.41
Average Target $50.74
High Target $70.04
Current Price $10.06
Current
$10.06
Target
$50.74
$34.41 $50.74 avg $70.04
Scenario Analysis
Bear Case
$34.41
242.0%
Low target
Base Case
$50.74
+404.4%
Avg target
Bull Case
$70.04
+596.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$18.31
-45.1% from high
52-Week Low
$2.21
+355.2% from low
Target vs 52W High
$50.74
+177.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%